150 related articles for article (PubMed ID: 9402177)
21. Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion.
Pedersen PH; Ness GO; Engebraaten O; Bjerkvig R; Lillehaug JR; Laerum OD
Int J Cancer; 1994 Jan; 56(2):255-61. PubMed ID: 8314309
[TBL] [Abstract][Full Text] [Related]
22. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
23. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
24. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
Majumdar K; Radotra BD; Vasishta RK; Pathak A
Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.
Hermansson M; Nistér M; Betsholtz C; Heldin CH; Westermark B; Funa K
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7748-52. PubMed ID: 2845420
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells.
Takeuchi H; Kanzawa T; Kondo Y; Kondo S
Br J Cancer; 2004 Mar; 90(5):1069-75. PubMed ID: 14997209
[TBL] [Abstract][Full Text] [Related]
28. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review.
Jensen RL
Surg Neurol; 1998 Feb; 49(2):189-95; discussion 196. PubMed ID: 9457270
[TBL] [Abstract][Full Text] [Related]
29. Neuregulin-1 enhances survival of human astrocytic glioma cells.
Ritch PS; Carroll SL; Sontheimer H
Glia; 2005 Aug; 51(3):217-28. PubMed ID: 15812817
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor (PDGF) in primary brain tumours of neuroglial origin.
Smits A; Funa K
Histol Histopathol; 1998 Apr; 13(2):511-20. PubMed ID: 9589905
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
33. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
34. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
[TBL] [Abstract][Full Text] [Related]
35. KDR activation in astrocytic neoplasms.
Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
[TBL] [Abstract][Full Text] [Related]
36. Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas.
Robinson S; Cohen M; Prayson R; Ransohoff RM; Tabrizi N; Miller RH
Neurosurgery; 2001 Apr; 48(4):864-73; discussion 873-4. PubMed ID: 11322447
[TBL] [Abstract][Full Text] [Related]
37. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
38. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
Tovi M; Hartman M; Lilja A; Ericsson A
Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
40. Synergism between growth-factors in the control of glioma cell-proliferation, migration and invasion in-vitro.
Merzak A; Koochekpour S; Dkhissi F; Raynal S; Lawrence D; Pilkington G
Int J Oncol; 1995 May; 6(5):1079-85. PubMed ID: 21556643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
